20/20 BioLabs to host Oct. 7 investor webinar on FDA advisory vote

The company said it will hold an investor webinar on Oct. 7, 2026 at 12:00 p.m. ET to discuss the Sept. 23, 2026 FDA advisory committee vote on GRAIL’s Galleri test and read-through for MCED regulation, plus its OneTest franchise model and early lab interest, followed by Q&A.